Cytokinetics Receives Orphan Drug Status for ALS Treatment
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Promising data from a Phase I clinical trial of CK-2017357 was announced in January.
Strategic Medicine (SMI) specializes in patient and disease stratification with the end goals of providing better healthcare and identifying unmet clinical needs.
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
Infectious Disease, Surgery, Orthopedics. This company has developed a surgical implant technological platform that serves as an antimicrobial framework indicated to preclude surgical site infections. […]
Pulmonology. Company has developed a compact, lightweight and patient-friendly ventilator system to improve respiratory care in the hospital and home markets. The company’s system is […]
Orthopedics, Surgery. Company has developed a minimally invasive spine stabilization system specifically designed to address the lower back pain seen in lumbar spinal diseases, including […]
Surgery, Neurology, Orthopedics. This company has developed a tissue resection system indicated for the removal of tumors and tissue from highly delicate areas including the […]
Neurology, Surgery. This company is developing an electrocorticography (ECG)-based brain computer interface to address motor impairments associated with neurodegenerative diseases and paralysis. Similar to technologies […]
Copyright © 2025 | WordPress Theme by MH Themes